CCC member Tora Solheim will be presenting the results from a randomised, open-label trial of a multimodal intervention (exercise, nutrition and anti-inflammatory medication) plus standard care versus standard care alone to attenuate cachexia in patients with advanced cancer undergoing chemotherapy in an oral presentation at ASCO 2024.
Comments